Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study

✍ Scribed by Enrico Balleari; Edoardo Rossi; Marino Clavio; Angela Congiu; Marco Gobbi; Marco Grosso; Vincenzo Secondo; Mauro Spriano; Silvana Timitilli; Riccardo Ghio

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 117 KB
• Volume: 85
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-005-0044-6